Trial NCT03346083

View at ClinicalTrials.gov 
Org. Study IDs: 16-021
Secondary IDs: 2018-002562-40

Last trial update was posted on 2024-01-12

MeSH Interventions

Betrixaban

MeSH Conditions


Other Conditions

VTE Prophylaxis

Stopping Reasons

After completion of Part 1 and prior to initiating Part 2, the Sponsor decided to cease developing betrixaban, prompting early study closure.

Limitations And Caveats

After completion of Part 1 and prior to initiating Part 2, the Sponsor decided to cease developing betrixaban, prompting early study closure.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID